Literature DB >> 6210375

Monoclonal antibody to intermediate filament proteins in astrocytes.

S K Pixley, Y Kobayashi, J de Vellis.   

Abstract

A monoclonal antibody was developed using rat astrocytes purified in vitro as the starting antigenic material. Selection of the monoclonal was on the basis of astrocyte binding specificity in brain sections using indirect immunofluorescence techniques. The antibody (RBA2) that was chosen was specific for astrocytes in that it did not stain neurons or oligodendrocytes in frozen brain sections. It did, however, show binding to vascular smooth muscle and meningeal cells. The antigenic determinant(s) was determined to be on filaments of the intermediate-size class in cultured astrocytes and fibroblasts. From analysis of binding patterns in various tissues and in immunoblots, it was found that RBA2 cross-reacted strongly with glial fibrillary acidic protein (GFAP) and desmin. There was a weaker cross-reactivity to a vimentin-associated component. It is proposed that this antibody can be used as an astrocyte and blood vessel marker in brain sections, a vimentin marker in cultures and as a probe of intermediate filament composition and distribution.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6210375     DOI: 10.1002/jnr.490120402

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  5 in total

1.  Characterization of cultured rat oligodendrocytes proliferating in a serum-free, chemically defined medium.

Authors:  R P Saneto; J de Vellis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  Immunohistochemical demonstration of vimentin in human cerebral tumors.

Authors:  D Schiffer; M T Giordana; A Mauro; A Migheli; I Germano; G Giaccone
Journal:  Acta Neuropathol       Date:  1986       Impact factor: 17.088

3.  MARCKS modulates radial progenitor placement, proliferation and organization in the developing cerebral cortex.

Authors:  Jill M Weimer; Yukako Yokota; Amelia Stanco; Deborah J Stumpo; Perry J Blackshear; E S Anton
Journal:  Development       Date:  2009-09       Impact factor: 6.868

4.  Unexpected immunoreactivities of intermediate filament antibodies in human brain and brain tumors.

Authors:  F E Franke; W Schachenmayr; M Osborn; M Altmannsberger
Journal:  Am J Pathol       Date:  1991-07       Impact factor: 4.307

5.  Microglial expression of peptidylarginine deiminase 2 in the prenatal rat brain.

Authors:  Hiroaki Asaga; Akihito Ishigami
Journal:  Cell Mol Biol Lett       Date:  2007-06-20       Impact factor: 5.787

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.